Marvin S.

Lakeland, FL

Marvin Receives Cellular Therapy for Chronic Obstructive Pulmonary Disease (COPD)

Age: 48 | Location: Lakeland, FL | Condition: COPD

Our 1,000th patient, Marvin S., refused to let chronic obstructive pulmonary disease (COPD) stand in the way of his hopes for the future. Before treatment, he fought recurring bouts of pneumonia. His doctors tried various medications and breathing treatments, but Marvin never felt better. Marvin eventually discovered the Lung Institute and received cellular therapy. Six months later, he’s pleased with his continued improvement.

Now, Marvin spends more time at work and playing with his baby. Because he is able to think more clearly, Marvin says his designs are better, and everyday activities are easier. He looks forward to spending more time outside fishing and working his cattle. Most importantly, he looks forward to enjoying his life. Marvin says that cellular therapy with the Lung Institute is “the best thing I’ve done.”

If you or a loved one has COPD, or any other form of lung disease, and would like to see results like Marvin’s, please contact one of our patient coordinators or call us at 888-745-6697.

Nancy H.
Bellingham, WA
David V.
Englewood, FL
Herbert K.
Keller, TX
Don C.
Lakewood, OH
Kathleen B.
Amherst, OH
Denise F.
Smiths Creek, MI
Judy Q.
French Village, MO
Penny K.
Omaha, NE
Ronnie G.
Warren, TX
Bill B.
Wellsboro, PA
Joseph O.
Selden, NY
Rhonda S.
Macomb, MI
Tammi S.
Cleveland, OH
Becky D.
Schererville, IN
Rickie S.
Elizabeth City, NC
Brad E.
Nashville, TN
Paul B.
Chagrin Falls, OH
Lois S.
Sun City, AZ
Karl T.
Hampstead, NC
June B.
Madeira Beach, FL
Jim D.
Boca Raton, FL
Marvin S.
Lakeland, FL
Vickie B.
San Antonio, TX
Audrey S.
Fairbanks, AK
Linus S.
Hays, KS

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.